… COVID-19 were admitted to our hospital, of whom 38 (10%) had a rheumatic or musculoskeletal
disease… Patients who died from COVID-19 were older (median age 78.4 IQR 74.5–83.5) …

… of different COVID-19 disease spectrum, including non-severe cases, severe cases, and …
antibody response during COVID-19 disease progression remained unknown in this study. …

… Patient of covid-19 pneumonia presents with wide range of … in COVID-19 are related with
disease progression, severity and … parameters in determination of COVID-19 disease severity. …

… found to be predictive of COVID-19 severity and may serve as potential biomarkers for
predicting COVID-19 progression and potential targets in therapeutic intervention of COVID-19. …

… trend was observed between mean age of patients with severe COVID-19 and log odds
of cerebrovascular disease and COVID-19 severity (correlation coefficient 0.1582, 95% CI: −…

… , and thrombocytopenia were associated with both hospitalization and disease severity. … of
severe COVID-19. It also finds clinical risk factors for hospitalization and severe COVID-19 not …

… Over 5,488,000 cases of coronavirus disease-19 (COVID-19) have been reported since …
in COVID-19 patients and assess the use of D-dimer as a biomarker for disease severity and …

… , we also aimed to correlate disease severity with CT findings. As expected, CT scores were
significantly lower in the mild category than in the severe and critical categories, confirming …

… disease severity in COVID-19 patients. The present meta-analysis was based on data from
7 studies on COVID-19 … than in non-survivors of COVID-19 patients. However, there was no …

… With the massive influx of studies on COVID-19 in the recent … with survival or disease severity
in patients with COVID-19 that takes … and disease severity among patients with COVID-19. …